Published in J Am Coll Cardiol on October 02, 2002
ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A (2005) 2.17
Energy metabolism in heart failure. J Physiol (2003) 2.10
PGC-1 coactivators in cardiac development and disease. Circ Res (2010) 1.86
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Quantitative cardiac 31P spectroscopy at 3 Tesla using adiabatic pulses. Magn Reson Med (2009) 1.83
Mitochondria in heart failure. Cardiovasc Res (2010) 1.75
Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol (2007) 1.74
Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res (2013) 1.72
Impaired ATP kinetics in failing in vivo mouse heart. Circ Cardiovasc Imaging (2010) 1.63
Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan (2014) 1.45
Cardiac aging: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal (2012) 1.40
Magnetic resonance Spectroscopy with Linear Algebraic Modeling (SLAM) for higher speed and sensitivity. J Magn Reson (2012) 1.37
A technique for in vivo mapping of myocardial creatine kinase metabolism. Nat Med (2014) 1.29
Mitochondrial centrality in heart failure. Heart Fail Rev (2008) 1.28
Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure. PLoS One (2012) 1.28
First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol (2014) 1.16
Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation (2009) 1.13
A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein. Mol Cell Proteomics (2009) 1.11
Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death. Sci Transl Med (2013) 1.08
Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant. Pediatr Nephrol (2012) 1.05
Mitochondria in the human heart. J Bioenerg Biomembr (2009) 1.03
Highly-accelerated quantitative 2D and 3D localized spectroscopy with linear algebraic modeling (SLAM) and sensitivity encoding. J Magn Reson (2013) 1.03
Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br J Pharmacol (2014) 1.00
A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia. Biochem Biophys Res Commun (2009) 0.99
Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart. Circ Res (2014) 0.98
Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance. Am J Physiol Heart Circ Physiol (2009) 0.97
New aspects of impaired mitochondrial function in heart failure. J Bioenerg Biomembr (2009) 0.95
Energetics and metabolism in the failing heart: important but poorly understood. Curr Opin Clin Nutr Metab Care (2010) 0.94
Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflugers Arch (2006) 0.90
Mitochondria and heart failure: new insights into an energetic problem. Minerva Cardioangiol (2010) 0.90
Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy. EMBO Mol Med (2014) 0.90
Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? Int J Mol Sci (2013) 0.89
Intracellular ATP binding is required to activate the slowly activating K+ channel I(Ks). Proc Natl Acad Sci U S A (2013) 0.88
Cardiac spectroscopy: techniques, indications and clinical results. Eur Radiol (2004) 0.87
Myocardial energetics in left ventricular hypertrophy. Curr Cardiol Rev (2009) 0.87
Human stanniocalcin-1 suppresses angiotensin II-induced superoxide generation in cardiomyocytes through UCP3-mediated anti-oxidant pathway. PLoS One (2012) 0.86
Electron transport chain dysfunction in neonatal pressure-overload hypertrophy precedes cardiomyocyte apoptosis independent of oxidative stress. J Thorac Cardiovasc Surg (2009) 0.86
MR spectroscopy in heart failure--clinical and experimental findings. Heart Fail Rev (2007) 0.86
Serendipity and the discovery of novel compounds that restore mitochondrial plasticity. Clin Pharmacol Ther (2014) 0.86
Prolongation of myocardial viability by proteasome inhibition during hypothermic organ preservation. Biochem Biophys Res Commun (2010) 0.85
Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series). Pulm Circ (2015) 0.85
Carboxyl terminus of Hsp70-interacting protein (CHIP) is required to modulate cardiac hypertrophy and attenuate autophagy during exercise. Cell Biochem Funct (2013) 0.83
Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol (2016) 0.83
Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association. Circ Res (2016) 0.82
(1)H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism. Heart Fail Rev (2013) 0.82
Cardiomyocyte autophagy: metabolic profit and loss. Heart Fail Rev (2013) 0.81
Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance. Front Biosci (Landmark Ed) (2009) 0.81
Increased COUP-TFII expression in adult hearts induces mitochondrial dysfunction resulting in heart failure. Nat Commun (2015) 0.81
A Myocardial Slice Culture Model Reveals Alpha-1A-Adrenergic Receptor Signaling in the Human Heart. JACC Basic Transl Sci (2016) 0.81
Proteasome inhibition prolongs survival during lethal hemorrhagic shock in rats. J Trauma Acute Care Surg (2013) 0.80
Quantification of human high-energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections. NMR Biomed (2013) 0.80
Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis. Oxid Med Cell Longev (2015) 0.80
Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease. Stem Cells (2016) 0.79
Mitochondria and oxidative stress in heart aging. Age (Dordr) (2016) 0.79
Mitochondrial dynamics in diabetic cardiomyopathy. Antioxid Redox Signal (2015) 0.79
Antifailure therapy including spironolactone improves left ventricular energy supply-demand relations in nonischemic dilated cardiomyopathy. J Am Heart Assoc (2014) 0.79
Creatine kinase rate constant in the human heart measured with 3D-localization at 7 tesla. Magn Reson Med (2016) 0.78
Metabolic remodeling in chronic heart failure. J Zhejiang Univ Sci B (2013) 0.78
Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure. Heart Fail Rev (2017) 0.77
On the theoretical limits of detecting cyclic changes in cardiac high-energy phosphates and creatine kinase reaction kinetics using in vivo ³¹P MRS. NMR Biomed (2015) 0.77
Activities of nonlysosomal proteolytic systems in skeletal and cardiac muscle during burn-induced hypermetabolism. J Burn Care Res (2014) 0.77
Taurine detected using high-resolution magic angle spinning (1)H nuclear magnetic resonance: A potential indicator of early myocardial infarction. Exp Ther Med (2012) 0.77
Cardioprotective effects of dietary lipids evident in the time-dependent alterations of cardiac function and gene expression following myocardial infarction. Physiol Rep (2014) 0.77
Metabolic enzymes dysregulation in heart failure: the prospective therapy. Heart Fail Rev (2016) 0.76
31P-MR spectroscopic imaging in hypertensive heart disease. Eur Radiol (2006) 0.76
Mitochondrial integrity in a neonatal bovine model of right ventricular dysfunction. Am J Physiol Lung Cell Mol Physiol (2014) 0.76
Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart. Life Sci (2015) 0.76
Normal cardiac function in mice with supraphysiological cardiac creatine levels. Am J Physiol Heart Circ Physiol (2013) 0.75
In vivo creatine kinase reaction kinetics at rest and stress in type II diabetic rat heart. Physiol Rep (2015) 0.75
Two repetition time saturation transfer (TwiST) with spill-over correction to measure creatine kinase reaction rates in human hearts. J Cardiovasc Magn Reson (2015) 0.75
Imaging based magnetic resonance spectroscopy (MRS) localization for quantitative neurochemical analysis and cerebral metabolism studies. Anal Biochem (2017) 0.75
Mechanisms of disease: is mitochondrial function altered in heart failure? Methodist Debakey Cardiovasc J (2013) 0.75
Phosphate imbalance in patients with heart failure. Heart Fail Rev (2017) 0.75
A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition. Heart Fail Rev (2017) 0.75
Metabolic Origins of Heart Failure. JACC Basic Transl Sci (2017) 0.75
Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol (2005) 5.63
Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson (2010) 4.10
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging (2013) 3.53
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson (2013) 3.52
Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson (2005) 3.47
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson (2009) 3.17
Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol (2007) 3.12
Aortic dilation in bicuspid aortic valve disease: flow pattern is a major contributor and differs with valve fusion type. Circ Cardiovasc Imaging (2013) 3.04
Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging (2012) 3.01
With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. J Am Coll Cardiol (2011) 2.99
Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol (2009) 2.57
Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation (2004) 2.50
The effect of obesity and weight loss on aortic pulse wave velocity as assessed by magnetic resonance imaging. Obesity (Silver Spring) (2010) 2.43
The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol (2009) 2.41
Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. J Am Coll Cardiol (2012) 2.38
Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 2.34
Early diagnosis of perioperative myocardial infarction after coronary bypass grafting: a study using biomarkers and cardiac magnetic resonance imaging. Ann Thorac Surg (2011) 2.27
Rapid identification and 3D reconstruction of complex cardiac malformations in transgenic mouse embryos using fast gradient echo sequence magnetic resonance imaging. J Mol Cell Cardiol (2003) 2.24
Preterm heart in adult life: cardiovascular magnetic resonance reveals distinct differences in left ventricular mass, geometry, and function. Circulation (2012) 2.21
Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation (2002) 2.10
Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson (2012) 2.03
Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique. BMC Dev Biol (2004) 2.01
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation (2003) 2.01
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging (2013) 1.99
nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation (2005) 1.97
Fast, high-resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7 T system. J Magn Reson Imaging (2003) 1.97
Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging (2011) 1.97
Assessment of motion gating strategies for mouse magnetic resonance at high magnetic fields. J Magn Reson Imaging (2004) 1.92
Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation (2004) 1.90
Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation (2005) 1.90
Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism? Hypertension (2010) 1.89
Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart (2013) 1.86
Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol (2007) 1.86
Quantitative 3-dimensional echocardiography for accurate and rapid cardiac phenotype characterization in mice. Circulation (2004) 1.79
Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol (2007) 1.78
Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: a comparison with coronary angiography and cardiac magnetic resonance. JACC Cardiovasc Imaging (2010) 1.71
Percutaneous treatment of chronic total coronary occlusions improves regional hyperemic myocardial blood flow and contractility: insights from quantitative cardiovascular magnetic resonance imaging. JACC Cardiovasc Interv (2008) 1.71
Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. Am J Cardiol (2006) 1.71
Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation (2013) 1.71
Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity. Heart (2010) 1.68
Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis. Circ Cardiovasc Imaging (2013) 1.67
Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation (2005) 1.67
Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson (2012) 1.67
Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol (2009) 1.66
Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease. Int J Cardiovasc Imaging (2008) 1.64
Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat Genet (2004) 1.61
Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging (2009) 1.61
Peripherally placed totally implantable venous-access port systems of the forearm: clinical experience in 763 consecutive patients. Cardiovasc Intervent Radiol (2010) 1.61
Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson (2013) 1.60
High-energy phosphotransfer in the failing mouse heart: role of adenylate kinase and glycolytic enzymes. Eur J Heart Fail (2010) 1.60
Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation (2012) 1.58
Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res (2003) 1.55
Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction. Cardiovasc Res (2007) 1.55
Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation (2007) 1.54
Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. J Cardiovasc Magn Reson (2007) 1.51
Effects of off-pump versus on-pump coronary artery bypass grafting on early and late right ventricular function. Circulation (2008) 1.49
T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med (2013) 1.45
Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy. J Am Coll Cardiol (2008) 1.43
Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender. J Cardiovasc Magn Reson (2013) 1.43
Late cerebral embolization after emboli-protected carotid artery stenting assessed by sequential diffusion-weighted magnetic resonance imaging. JACC Cardiovasc Interv (2008) 1.42
How to perform an accurate assessment of cardiac function in mice using high-resolution magnetic resonance imaging. J Cardiovasc Magn Reson (2006) 1.42
Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol (2004) 1.41
Endovascular reconstruction of the aortic bifurcation in patients with Leriche syndrome. Clin Res Cardiol (2009) 1.41
Novel insights into LV remodeling after murine myocardial infarction by in vivo magnetic resonance tissue velocity mapping. Int J Cardiovasc Imaging (2004) 1.39
Tako-tsubo cardiomyopathy presenting with features of left ventricular non-compaction. Int J Cardiol (2007) 1.39
Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg (2011) 1.39
Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet (2004) 1.37
Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study. JACC Cardiovasc Imaging (2012) 1.35
Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab (2012) 1.35
Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation (2005) 1.33
Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation (2012) 1.32
VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5. Genes Dev (2008) 1.32
Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches. J Cardiovasc Magn Reson (2013) 1.31
Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation (2005) 1.30
Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry. Obes Res (2004) 1.29
High-resolution, high-throughput magnetic paragraph sign resonance imaging of mouse embryonic paragraph sign anatomy using a fast gradient-echo sequence. MAGMA (2003) 1.28
High-resolution imaging of normal anatomy, and neural and adrenal malformations in mouse embryos using magnetic resonance microscopy. J Anat (2003) 1.26
Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson (2014) 1.26
Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease. Circulation (2011) 1.24
Computer-assisted detection of pulmonary nodules: performance evaluation of an expert knowledge-based detection system in consensus reading with experienced and inexperienced chest radiologists. Eur Radiol (2004) 1.23
Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2009) 1.22
Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism. Pediatrics (2012) 1.22
Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol (2006) 1.21
Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation (2007) 1.21
Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia. J Am Coll Cardiol (2010) 1.19
Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J Mol Cell Cardiol (2008) 1.19
Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI. Am J Physiol Heart Circ Physiol (2009) 1.19
Myocardial tissue phase mapping with cine phase-contrast mr imaging: regional wall motion analysis in healthy volunteers. Radiology (2006) 1.18
Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Pediatr Radiol (2012) 1.18
Rapid regulation of platelet activation in vivo by nitric oxide. Circulation (2004) 1.17
The creatine kinase energy transport system in the failing mouse heart. J Mol Cell Cardiol (2007) 1.17
Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart. Am J Physiol Heart Circ Physiol (2009) 1.17
Prebolus quantitative MR heart perfusion imaging. Magn Reson Med (2004) 1.17